Dr. Matthias Krings

Matthias is a founding Partner of Catenion who lives in Munich and Berlin, Germany. Matthias became a consultant in 1999 at Mercer Management Consulting and later joined a strategy consulting boutique, Theron. In 2003, he co−founded Catenion.

Matthias has worked for European and global client organisations on pharmaceutical strategy with a particular focus on R&D portfolio management. He has co−developed and applied specialised approaches and tools to assess and mitigate the technical and scientific risks of pharmaceutical R&D projects, as well as link these methods and tools to portfolio−level decision−making. Matthias continuously helps clients master Catenion’s consulting approaches and embed them into management routines.

In 2007, Matthias spearheaded the launch of the executive training and education unit of Catenion, The Catenion Academy, with the goal of significantly improving the way clients manage R&D.

Before commencing his studies, Matthias lived and worked in Florida for a year. He holds a diploma and a doctorate degree in biology from the Ludwig−Maximilians University in Munich. His PhD work was supported by a scholarship from the Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine. During his academic period, Matthias made significant scientific contributions to the field of human evolution. Matthias’ and his research team’s analysis of the first−ever DNA sequence from the Neanderthal−type specimen in 1997 continues to be one of the most frequently cited papers in the field of evolution. This and subsequent studies showed that Neanderthal mitochondrial DNA falls outside the variation of contemporary modern humans, suggesting that little or no interbreeding may have taken place between the two.

In private, Matthias likes to be with family and friends. He enjoys a variety of music, gardening, cooking, and water sports and is interested in human evolution and evolutionary psychology.